Allo and auto-reactive t-cell epitopes

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/705 (2006.01) A61K 38/17 (2006.01) A61P 37/02 (2006.01) G01N 33/569 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2353523

The present invention relates to a pharmaceutical composition for the prevention of alloimmunisation of a subject or the immunosuppression of a response elicited by alloimmunisation of a subject or an autoimmune haemolytic disease for said composition comprising an immunologically effective epitope of a rhesus protein or an immunologically active analogue or derivative thereof.

La présente invention se rapporte à une composition pharmaceutique permettant de prévenir l'alloimmunisation d'un sujet ou l'immunosuppression d'une réponse sollicitée par l'alloimmunisation d'un sujet ou une maladie hémolytique auto-immune. Cette composition comporte un épitope immunologiquement actif d'une protéine rhésus ou un analogue immunologiquement actif ou un dérivé d'une telle protéine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Allo and auto-reactive t-cell epitopes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Allo and auto-reactive t-cell epitopes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allo and auto-reactive t-cell epitopes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1554832

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.